Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Lascols

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathyF Caux, E Dubosclard, O Lascols, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalitiesM C Vantyghem, P Pigny, C A Maurage, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2008
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophyM C Vantyghem, D Vincent-Desplanques, F Defrance-Faivre, et al.
Diabetes|November 15, 2000
Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophyC Vigouroux, J Magré, M C Vantyghem, et al.
Diabetes, Obesity & Metabolism|November 21, 2015
One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromesC Vatier, S Fetita, P Boudou, et al.
British Journal of Cancer|November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeatsJ-F You, O Buhard, M J L Ligtenberg, et al.
ESMO Open|April 30, 2021
Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancerA Guyot D'Asnières De Salins, G Tachon, R Cohen, et al.
Orphanet Journal of Rare Diseases|April 20, 2022
Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)H Mosbah, B Donadille, C Vatier, et al.
Clinical Genetics|October 27, 2015
Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and managementM Avila, D A Dyment, J V Sagen, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathyF Caux, E Dubosclard, O Lascols, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Patients with familial partial lipodystrophy of the Dunnigan type due to a LMNA R482W mutation show muscular and cardiac abnormalitiesM C Vantyghem, P Pigny, C A Maurage, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2008
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophyM C Vantyghem, D Vincent-Desplanques, F Defrance-Faivre, et al.
Diabetes|November 15, 2000
Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophyC Vigouroux, J Magré, M C Vantyghem, et al.
Diabetes, Obesity & Metabolism|November 21, 2015
One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromesC Vatier, S Fetita, P Boudou, et al.
British Journal of Cancer|November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeatsJ-F You, O Buhard, M J L Ligtenberg, et al.
ESMO Open|April 30, 2021
Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancerA Guyot D'Asnières De Salins, G Tachon, R Cohen, et al.
Orphanet Journal of Rare Diseases|April 20, 2022
Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)H Mosbah, B Donadille, C Vatier, et al.
Clinical Genetics|October 27, 2015
Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: toward recommendation for molecular testing and managementM Avila, D A Dyment, J V Sagen, et al.
Pageof 4